Table 1 Some of targeted therapies in control and treatment of asthma
Target | Effects | Th2high/low | References | |
---|---|---|---|---|
Cell surface protein | Siglec-8 | Apoptosis of eosinophils | High | |
CD300a | Activation of inhibitory receptor | High | ||
α4β1, α4β7 | Increase blood eosinophils and inhibits their tissue accumulation | High | ||
CCR3 | Block chemokine-induced eosinophils | High | ||
CXCR2 | Reduce neutrophils | Low | ||
CD52 | Deplete eosinophils | High | ||
EMR1 | Deplete primate eosinophils | High | ||
CRTH2 | Reduce tissue eosinophils | High | ||
Transcription factor | GATA3 | Reduce IL-5 | High | |
Soluble mediator antagonist | Eotaxin-1 | Inhibit eosinophil migration | High | |
IgE | Reduces allergic inflammation and exacerbations and airway obstruction | High | ||
IL-4 | Reduce allergic inflammation | High | ||
IL-13 | Reduce airway obstruction and cough | High | ||
Interleukin-17RA | Reduce Th17 response | Low | ||
TSLP | Reduce eosinophils and allergic inflammation | High | ||
PGD2 | improved Lung function | High |